Suppression of 6-pyruvoyl-tetrahydropterin synthase promotes remyelination in multiple sclerosis

Our findings suggest that PTS is a negative regulator of OPC proliferation, and its disinhibition could offer a potential therapeutic target for MS.

Authors

Institutions

Publication Details

Journal
BMC Medicine
Published
2025-11-06
DOI
https://doi.org/10.1186/s12916-025-04351-0
Primary Topic
Mitochondrial Function and Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Suppression of 6-pyruvoyl-tetrahydropterin synthase promotes remyelination in multiple sclerosis

Ying Long, Yanqing Yin, Ellen Ji, Hui Xiao et al.
BMC Medicine
Mitochondrial Function and Pathology
article

Suppression of 6-pyruvoyl-tetrahydropterin synthase promotes remyelination in multiple sclerosis

Ying Long, Yanqing Yin, Ellen Ji, Hui Xiao, Gang Hu, Yue Wu, Yong-shun Guo, Jiawei Zhou, Yanyan Zhu, Jun Gao
article en

Abstract

Our findings suggest that PTS is a negative regulator of OPC proliferation, and its disinhibition could offer a potential therapeutic target for MS.

BMC MedicineVol. 23(1)
Nanjing University of Chinese Medicine (CN), Chinese Academy of Sciences (CN), Nantong University (CN), Center for Excellence in Brain Science and Intelligence Technology (CN), University of Chinese Academy of Sciences (CN), Nanjing Medical University (CN)
Openalex Percentile: Top 71%
Mitochondrial Function and Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.